March 2020

Researchers Say Combination Of Lenvatinib And Pembrolizumab Showed “Compelling Efficacy” For Treatment Of Advanced Endometrial Carcinoma

Posted on March 27, 2020 by Womens Cancer Care

MedPage Today (3/26, Jenkins) reports researchers found in a phase 1b/2 trial that the combination of lenvatinib and pembrolizumab showed “compelling efficacy” for the treatment of “advanced endometrial carcinoma, regardless of tumor microsatellite instability status.” The researchers found “a 38% objective response rate at 24 weeks among the 108 women with advanced endometrial carcinoma treated […]

Ovarian Cancer News

Posted on March 25, 2020 by Womens Cancer Care

Leading the News Cellular Recycling Genes Associated With Ovarian Tumor Formation Ovarian Cancer News Today (3/23, Bryson) reports that research in mice indicates that “disrupting genes essential for the cellular recycling process known as autophagy increases the frequency of mutations during cell division and promotes the formation of ovarian cancer tumors.” The research was published in PLOS Genetics […]

Significant Number Of Older Women With Breast Cancer May Have Genetic Mutations That Put Them At Risk Of Ovarian, Other Cancers

Posted on March 11, 2020 by Womens Cancer Care

HealthDay (3/10, Gordon) reports, “A significant number of older women with breast cancer may have genetic mutations that put them at risk of additional cancers, particularly ovarian cancer, a new study finds.” In the study, published March 10 in the Journal of the American Medical Association, “the researchers said that as many as one in 40 postmenopausal women […]